Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127365791 | 12736579 | 1 | I | 20160808 | 20160822 | 20160912 | 20160912 | PER | US-ASTRAZENECA-2016SE90603 | ASTRAZENECA | 24789.00 | DY | F | Y | 108.90000 | KG | 20160912 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127365791 | 12736579 | 1 | PS | ANASTRAZOLE | ANASTROZOLE | 1 | Oral | N | U | 20541 | TABLET | ||||||||
| 127365791 | 12736579 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 150 | MG | N | U | 708BH | 0 | 25 | MG | TABLET | QD | ||
| 127365791 | 12736579 | 3 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 4 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 5 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 6 | C | OTHER MEDICATION | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 8 | C | HUMULIN NOS | INSULIN HUMAN | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 10 | C | ALEVE | NAPROXEN SODIUM | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 11 | C | ALEVE | NAPROXEN SODIUM | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 12 | C | ALEVE | NAPROXEN SODIUM | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 13 | C | SHAKLEE MULTIVITAMIN | 2 | 0 | |||||||||||||
| 127365791 | 12736579 | 14 | C | VITAMIN B | VITAMIN B | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 15 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 16 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 127365791 | 12736579 | 17 | C | CINNAMON EXTRACT | 2 | 0 | |||||||||||||
| 127365791 | 12736579 | 18 | C | WOLFBERRIES | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127365791 | 12736579 | 1 | Breast cancer |
| 127365791 | 12736579 | 2 | Breast cancer |
| 127365791 | 12736579 | 3 | Blood pressure abnormal |
| 127365791 | 12736579 | 4 | Blood pressure abnormal |
| 127365791 | 12736579 | 5 | Blood pressure abnormal |
| 127365791 | 12736579 | 6 | Thyroid disorder |
| 127365791 | 12736579 | 7 | Diabetes mellitus |
| 127365791 | 12736579 | 8 | Diabetes mellitus |
| 127365791 | 12736579 | 9 | Cardiac disorder |
| 127365791 | 12736579 | 10 | Spinal column stenosis |
| 127365791 | 12736579 | 11 | Back pain |
| 127365791 | 12736579 | 12 | Pain in extremity |
| 127365791 | 12736579 | 14 | Ill-defined disorder |
| 127365791 | 12736579 | 15 | Bone disorder |
| 127365791 | 12736579 | 16 | Bone disorder |
| 127365791 | 12736579 | 17 | Diabetes mellitus |
| 127365791 | 12736579 | 18 | Antioxidant therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127365791 | 12736579 | Dermatitis allergic | |
| 127365791 | 12736579 | Hypersensitivity | |
| 127365791 | 12736579 | Myalgia | |
| 127365791 | 12736579 | Pain in extremity | |
| 127365791 | 12736579 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127365791 | 12736579 | 1 | 20160713 | 0 | ||
| 127365791 | 12736579 | 2 | 20160804 | 20160809 | 0 |